CCR2 and central nervous system cancer: In our study of a murine glioma model, the reduced accumulation of TAMs in Ccr2-deficient mice is accompanied by increased tumor volumes based on the enhanced proliferation of glioma cells, changes in their inflammatory gene expression and improved integrity of tumor blood vessels.